Research & Development News
Research & Development news
-
News Colorcon opens in Australia to meet growing demand from local pharma industry
Customers in the region will have the opportunity to conduct laboratory-scale compression and coating trials, using automated coating equipment. -
News Oxford Biomedica signs 3-year CSA for Parkinson’s disease gene therapy program
The company expects to manufacture the clinical-stage gene therapy product in its commercial-scale GMP manufacturing facilities. -
News Pfizer and BioNTech to supply Japan with 120 million doses of mRNA-based vaccine candidate
The companies are set to manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021. -
News Construction underway on new Croda North American HQ and Innovation Centre
The facility will support the company'a goal of being climate, land and people positive by 2030. -
News Vital Signs Solutions receives backing to facilitate mass-scale antibody testing for COVID-19
The company will adapt its digital platform to digitize any COVID-19 antibody rapid test assay and embed this within an app available on smartphones and tablets. -
News Stevanato Group and Colanar colaborate to study container closure systems
The data generated through the partnership will help biopharma companies to develop robust manufacturing processes and minimize challenges during scale-up and commercialization. -
News Colorcon launches new enteric coating with pH up to 5.0
Acryl-EZE formulations provide significant time savings and targeted drug delivery. -
News Humanigen expands partnership with Catalent to manufacture investigational COVID-19 therapeutic candidate
Data on the first clinical use of lenzilumab in patients with severe COVID-19 pneumonia suggest promising results. -
News Arctoris supports global research efforts to find new therapeutics against COVID-19
The company is also involved in projects that aim to enable population-level screening for the current coronavirus. -
News Cobra Biologics delivers final plasmids for CombiGene's epilepsy project
Further milestone paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy. -
News Merck KGaA opens its largest M Lab Collaboration Center in Shanghai
The center will host a new BioReliance End-to-End Solutions GMP manufacturing facility offering CDMO services to customers in China and Asia-Pacific. -
News Vetter further expands its development service with new site in Austria
The CDMO responds to the growing demand for complex fill and finish solutions. -
News Regeneron wins $450 million US government manufacturing agreement for anti-viral antibody cocktail
The company began scaling up manufacturing of REGN-COV2 at business risk earlier this year to ensure the immediate availability of the product if clinical trials prove successful. -
News SGS joins with Biophytis to launch international trial of COVID-19 related respiratory failure treatment
The CRO will undertake this clinical trial at multiple sites worldwide, starting at the AZ Sint Maarten hospital in Mechelen, Belgium. -
News Ajinomoto introduces fast track platform for drug product manufacturing
AJILITY is designed to speed novel or existing therapeutics from development to manufacturing and into the clinic. -
News Catalent and ViralClear Pharmaceuticals partner on potential COVID-19 treatment
The CDMO will work on developing a solution and a solid oral dosage form of ViralClear's merimepodib. -
News Sanofi to build EUR 490 million vaccine production facility in France
The French pharma company will also invest EUR 120 million to create a new research center at Marcy-l'Etoile dedicated to vaccines -
News Vektor Pharma finalizes formula for novel transdermal drug delivery system to treat Parkinson's
Optimizing the dosage form's efficiency reduces the amount of drug required in each patch. -
News Emergent bags $628 million "landmark" CDMO deal to produce COVID-19 vaccine candidates
The company will provide CDMO capabilities, capacities, and expertise to support the US government’s Warp Speed Program to pave the way for innovators to advance COVID-19 programs. -
News SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient
SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor. -
News Changes needed to prevent controversial pay-for-delay pharma deals
Researchers endorse a switch from the current first-filer system in the US to a system that instead rewards the first successful challenger. -
News HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment
The invention could pave the way for treatments to cure Parkinson's and Alzheimer's disease. -
News AbCellera and Lilly seal multi-year antibody discovery collaboration
AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets. -
News HKBU scientists develop technique to eliminate drug side effects
The novel method paves the way towards the mass production of affordable therapeutic drugs that are made with recyclable materials. -
News Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit
CDMO is contracted to produce multiple clinical batches from German facility -
News Characterizing virus and virus-like particles
New application study describes the separation and characterisation of adeno associated virus serotypes by AF4. -
News AI technology company launches with Novartis and Sarepta deals
Collaborations focus on gene therapies for serious eye and muscle diseases using Dyno’s CapsidMap artificial intelligence platform to design AAV vectors. -
News Bio-Rad launches anti-certolizumab pegol antibodies
Using this critical antibody reagent at the preclinical stage of development will minimize the need to revalidate assays with different reagents at the clinical development stage. -
News AstraZeneca "incredibly excited" by lung cancer treatment trial
Independent Data Monitoring Committee (IDMC) recommends unblind Phase III trial of Tagrisso 2 years ahead of schedule. -
News BERG named visionary in first-ever Frost Radar AI in Drug Discovery report
The biotech pioneer is one of the first companies to develop corporate partnerships in this application of artificial intelligence (AI) for drug discovery. -
News German pharma companies are meeting the corona "stress test"
The head of the leading German pharmaceutical industry organization says German firms are working top-speed to find coronavirus medications. -
News Evotec expands into gene therapy with new Austrian unit
Evotec has established a dedicated gene therapy-based R&D site in Orth an der Donau, Austria with the immediate focus of spearheading a partnership with Japan’s Takeda to support its research projects, the German drug discovery firm said Monday. -
News Servier strengthens its R&D pipeline with Symphogen acquisition
Symphogen becomes the antibody center of excellence within Servier. -
News World’s leading biobanks join a global network to advance personalized healthcare research
The platform enables collaboration between pharmaceutical institutions, healthcare and academic researchers to generate valuable insights and advance medical research. -
News European patent granted for amatoxin conjugates for tumor therapy
The patent covers the crosslinking of certain carrier molecules, for example, antibodies, via specific binding sites to amatoxins. -
News New blood test able to detect 50 cancer types
Study data support blood test's ability to detect 50 types of cancer and identify where in the body the cancer is located. -
News Alvotech and DKSH partner to bring key biosimilar to Asia
Together, the companies will provide APAC markets with a cost-effective alternative to the largest-selling blockbuster medicine worldwide. -
News Positive update on the development of new XF‐platform drug formulations
Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for dermal and ocular infections. -
News ProBioGen selected for development and large-scale manufacturing services
The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development. -
News Codexis and Takeda collaborate to advance novel gene therapies
Partnership to leverage Codexis’ protein engineering platform for the discovery and development of novel transgenes for lysosomal storage disorders and blood factor deficiencies. -
News Vaxxas HD-MAP to deliver vaccines directly to the skin
Company awarded US$5 million grant for clinical study of measles and rubella vaccination using Vaxxas’ high-density, micro-array patch. -
News Technique improves drug delivery system characterization
Postnova Analytics' CF2000 Centrifugal Field Flow Fractionation (CF3) system is delivering exciting new data to scientists developing drug delivery systems. -
News Regeneron and Sanofi begin global Kevzara clinical trial program in patients with severe COVID-19
The trial is the first controlled trial in the US to evaluate the effect of IL-6 inhibition prospectively in COVID-19 patients. -
News Sartorius simplifies biologics production with new bioreactor
Company launches BIOSTAT STR Generation 3 bioreactor with BIOBRAIN automation platform. -
News Bristol Myers Squibb "disappointed" with failed late-stage combo drug trial
Phase III study evaluating Empliciti plus Revlimid and dexamethasone in patients with newly diagnosed, untreated multiple myeloma fails to meet primary endpoint. -
News Nanoform and Orion collaborate on 'nanoformed' APIs
Active pharmaceutical ingredients (APIs) nanoformed using the CESS process demonstrate promise for overcoming solubility and bioavailability challenges. -
News Gilead to boost R&D pipeline with $4.9 billion deal for Forty Seven
Biotech firm Gilead Sciences said Monday it is set to acquire clinical-stage oncology specialist Forty Seven in a transaction worth $4.9 billion. -
News MindMed becomes world's first psychedelic pharma company to go public
The company’s immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine. -
News Potential first-in-class treatment reaches significant milestone
The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis. -
News Merck KGaA, AMCM/EOS co-operate in 3D printing of tablets
A cooperation agreement between German pharma firm Merck KGaA and additive manufacturing specialist AMCM on 3D printing of tablets could eventually lead to scalable active pharmaceutical ingredient (API) formulation and faster, cheaper production, the ... -
News BIA Separations signs agreement to commercialise novel elution technology
Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy. -
News Non-hormonal treatment for menopausal hot flashes begins clinical trials
The study will evaluate the efficacy of SJX-653 in reducing the frequency and severity of VMS due to menopause, as well as improving measures of sleep and quality of life. -
News Novartis receives EC Approval for next-gen anti-VEGF treatment for wet AMD
Beovu is the only anti-VEGF treatment approved in Europe for wet AMD that offers the option to start eligible patients on 3-month dosing intervals immediately after the loading phase. -
News Gene Therapy: A Complex and Evolving Manufacturing Challenge
Gene therapies have the potential to revolutionize treatment options for patients suffering from cancer, cystic fibrosis, heart disease, diabetes, Parkinson's, AIDS and Alzheimer's by replacing, inactivating or introducing genes into cells &mda... -
News New Velesco Pharma clinical manufacturing facility begins operations
The facility will triple the company’s cGMP clinical trial manufacturing capacity. -
News Thinking Outside the Box, What's Driving R&D in Pharma Packaging?
Evolving patient needs, growing demand for traceability and increasing cost pressures have awakened innovation in the pharmaceutical packaging sector. -
News Inovio and Beijing Advaccine to advance vaccine against Coronavirus
Agreement will facilitate clinical trial translations in China. -
News First human trial of monoclonal antibody to prevent malaria opens
If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common. -
News Merck invests in biotech development facility in Switzerland
€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing. -
News Diabetes diagnosis - now a matter of sweat and tears?
No need to draw blood; researchers develop smart technology to diagnose diabetes and treat diabetic retinopathy. -
News Grey Wolf Therapeutics secures funding for cancer therapies development
The company targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system. -
News BioMarin gets go-ahead to start gene therapy clinical trials
BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program. -
News French regulator agrees to partial resumption of Tellomak trial patient recruitment
The French National Agency for Medicines and Health Product Safety (ANSM) has agreed that Innate Pharma’s Tellomak (lacutamab) Phase II trial can resume recruitment of new patients with relapsed/refractory Sézary syndrome and mycosis fungoides (MF) in ... -
News Biogen to acquire novel clinical-stage asset from Pfizer
PF-05251749 complements the company’s pipeline of potential disease-modifying therapies for Alzheimer’s and Parkinson’s diseases. -
News Partnership formed to develop and commercialise ready-to-use medicine
The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products. -
News ReadCoor to commercially launch spatial sequencing platform
Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine. -
News New HQ for developer of world's first fully automated drug discovery platform
End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery data. -
News NIH researchers discover new autoinflammatory disease
Mutations in the RIPK1 gene responsible for CRIA syndrome. -
News BioAscent scientists help identify potential new treatments for cancer
Collaboration discovers potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases. -
News NIH launches first US clinical trial of patient-derived stem cell therapy to replace dying cells in retina
NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment. -
News Sanofi bolsters its immuno-oncology pipeline for $2.5B
Lead asset THOR-707 being explored across multiple solid tumor types alone and in combination with immune checkpoint inhibitors and other future IO combinations. -
News Ground-breaking work creates novel oil-in-water nanoemulsions
New innovation has considerable potential to be used as a new environmentally friendly matrix for the microencapsulation and controlled release of a wide range of actives. -
News Eli Lilly unveils shared innovation laboratory in San Francisco
Lilly Gateway Labs will provide biotech companies direct access to Lilly scientists and expertise. -
News UK experiences a 'baby boom' of new life sciences ventures
Unprecedented levels of investment cited as a major force driving the expansion. -
News Recipharm joins the AMR Industry Alliance
Marks the latest step in the company’s ongoing efforts to engage with other organisations working to tackle antimicrobial resistance. -
News In vitro disease models that could lead to new therapies
New models can help researchers investigate disease development and find new treatment approaches. -
News CDMOs to benefit from rising BTDs, orphan drugs and fast track status therapies
But personalized medicines will require new logistics and manufacturing systems. -
News Recipharm launches new service to support companies with QC and analytical requirements
Services including method development, method validation, and stability program design and implementation. -
News FDA approves first and only medicine in a new class of acute treatment for migraine
The approval of Eli Lilly's Reyvow represents the first new class of acute migraine treatment approved by the FDA in more than two decades. -
News Lonza’s Ibex solutions to support Genmab’s growing clinical portfolio
Company's Ibex Design planned to take Genmab’s pre-clinical candidates from gene to potential IND within 12 months. -
News Funding to accelerate delivery of Univercells' vaccine portfolio
European financing to support Univercells’ R&D investments to develop four essential and undersupplied global health vaccines to be produced at affordable prices, high quality and large volumes. -
News Industrial-scale manufacture of therapeutic exosomes
Coordinated purification process development service accelerates progress to clinical trials, and scale-up manufacturing. -
News BASF and Biomillenia join forces in microbiome research to promote healthy skin
Research aims to identify novel dermocosmetic active ingredients via unique microbiome-on-a-chip technology. -
News Data on lead ADC demonstrates effective tumour regression
IKS01 shows marked anti-tumour efficacy in pre-clinical models of ovarian and lung cancer. -
News Arctoris secures funding to advance novel robotic drug discovery platform
Platform will enable scientists and biotechnology entrepreneurs worldwide to make discoveries faster and more efficiently, -
News EC approves its first plant-derived cannabis-based medicine
Epidyolex (cannabidiol) approved for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy. -
News Researchers develop less toxic anti-cancer drug
New drug works like a ‘magic bullet’ that is delivered directly to the mitochondria of cancer cells. -
News M2i Life Sciences completes a historic fundraising of 60 million Euros
To support its strong growth, M2i Life Sciences has concluded a capital increase of 60 million Euros with five leading investors (ADM Capital, Eurazeo Growth, Téthys Invest, Creadev and France 2i fund managed by RAISE Impact). -
News Study demonstrates potential of blood test for early lung cancer detection
Ground-breaking trial demonstrates potential of blood test which harnesses the power of the immune system to reduce late detection of lung cancer. -
News FUJIFILM Irvine Scientific launches BalanCD Gal Supplement for biotherapeutic development
Delivers enhanced galactosylation for improved protein quality, and antibody binding and function. -
News BioCity backs world's first Rx to OTC switch incubator
Maxwellia considered to have the skills and the expertise to deliver and reach their goal of creating the big OTC brands of the future. -
News Dutch company receives €20 million for skin cancer diagnostic test
The test can accurately predict the risk of having metastases present in the lymph nodes without having to undergo surgery to remove lymph nodes. -
News AbbVie axes Rovalpituzumab Tesirine R&D program
Independent Data Monitoring Committee recommended terminating the study due to lack of survival benefit. -
News Improving anxiety-induced insomnia with lavender oil
New data shows pharmaceutical-quality lavender oil significantly improves anxiety-induced insomnia when taken as a daily capsule. -
News Exciting new vaccine targets killer disease TB
Australian researchers produce early-stage vaccine which is inhaled into the lungs. -
News Grant from Innovate UK to fund gel stabilisation technologies development
Atelerix Consortium awarded £267,000 Innovate UK Grant for collaboration with the Cell and Gene Therapy Catapult and Rexgenero on cell therapy stabilisation technologies. -
News Rapid adoption of Carterra’s LSA instrument drives European expansion
Company's antibody screening platform minimizes the risk of missing a blockbuster. -
News IDT launches oPools Oligo Pools
The longest, highest fidelity, and ready-to-use custom oligo pools on the market. -
News FDA Approves rfxcel for Verification Router Service (VRS) Pilot
rfxcel, the global leader in supply chain compliance and serialization solutions, has been approved by the U.S. Food and Drug Administration (FDA) to conduct a pilot to extend the testing of the Verification Router Service (VRS) for saleable returns. -
News rfxcel Awarded ISO 9001:2015 Certification
rfxcel, the leader in track and trace solutions for global supply chains announced that it is now ISO 9001:2015 certified for Quality Management Systems. -
News How real-world data can revolutionise drug development
Utilising the current data environment and its data pools for the benefit of advancing research. -
News Using mobile phones to fight Alzheimer’s disease
Researchers study how radiofrequency electromagnetic fields could be used in Alzheimer’s disease therapy. -
News Researchers develop 3D printed ingestible pill
Represents the first non-invasive diagnostic tool capable of providing a profile of microbiome populations throughout the entire GI tract. -
News Needle free: Erase wrinkles without injection
Meet REVOLUTION BEYOND INNOVATION at Cphi Worldwide 2019, Booth No. 42C06 -
News Eisai collaborates with University of Dundee on cancer drug discovery
It is hoped that research into PROTACs will lead to new drug discoveries for proteins present in cancer, which are difficult to treat with conventional small molecule inhibitors. -
News Fresh data on protein interactions in Alzheimer’s disease
Demonstrates the unique ability of diffusional sizing to assess protein binding in-solution and for difficult-to-study systems. -
News Cyclolab Ltd strengthens its position in the market
Cyclolab Ltd. is an R&D and cGMP manufacturing company focusing on all aspects of cyclodextrin science, manufacturing and applications for cyclodextrin, Dexolve, Sugammadex, formulation development, custom synthesis, Niemann Pick C. -
News Inaugural Bio Integrates conference highlights industry's inefficiency in developing products
Industry leaders give voice to issues and trends shaping the biotech sector, including the importance of collaboration. -
News Clinical supply milestone reached for triple-negative breast cancer treatment
PhoenixMD and WuXi STA have produced a multikilogram drug supply for PMD-026 under GMP manufacturing practices. -
News Trial finds vitamin D does not prevent type 2 diabetes in people at high risk
No meaningful difference between the two study groups regardless of age, sex, race or ethnicity. -
News Partnership seeks breath biomarkers for the early detection of malignant mesothelioma
Owlstone Medical and IAHFIAW to use Breath Biopsy to examine the chemicals found on the breath of individuals with documented historical exposure to asbestos and radiologically and histologically confirmed mesothelioma. -
News Lilly gets its hands on non-opioid pain asset
Early-phase molecule from Centrexion to be developed further as a potential non-opioid treatment option for multiple pain conditions. -
News Updated clinical trial simulation software saves time and money
One customer saves $25m and 3 years' development time in their clinical development strategy. -
News Merck bolsters oncology pipeline with acquisition
Acquisition includes novel late-stage renal cell carcinoma candidate, PT2977. -
News Follicum files patent application for new topical formulation for hair loss
Using easy-to-apply cream instead of direct scalp injection would extend patent protection by 8 years. -
News Hovione Technology acquires global rights to new pulmonary inhaler device
The Papillon DPI is a single-part, blister-based, reusable inhaler, suitable for both chronic and acute treatments. -
News Isotype-specific secondary antibodies for improved signal detection
Offers an alternative to cross-adsorbed secondary antibodies when absolute specificity is required. -
News Sterling Pharma to acquire CiVentiChem in the US
The acquisition will enhance the CDMO's chemistry development capabilities to support pre-clinical and early phase clinical supply. -
News 'Drugs from bugs' joint venture
Lonza and Chr. Hansen create a strategic joint venture to become the partner of choice for developing and manufacturing live biotherapeutic products for pharma and biotech customers. -
News Curcumin and pomegrantes - new hope for Alzheimer’s prevention?
New research at University of Warwick will test how curcumin kick-starts the brain’s cleansing of damaging plaques and cells.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance